Cinctive Capital Management LP Has $8.62 Million Stock Position in Encompass Health Co. (NYSE:EHC)

Cinctive Capital Management LP increased its position in Encompass Health Co. (NYSE:EHC - Free Report) by 143.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 93,312 shares of the company's stock after buying an additional 54,931 shares during the quarter. Cinctive Capital Management LP owned about 0.09% of Encompass Health worth $8,617,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB boosted its position in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after purchasing an additional 137 shares in the last quarter. CBIZ Investment Advisory Services LLC grew its position in Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after buying an additional 127 shares during the last quarter. Tompkins Financial Corp bought a new position in shares of Encompass Health in the fourth quarter valued at $46,000. V Square Quantitative Management LLC lifted its position in shares of Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after acquiring an additional 177 shares during the last quarter. Finally, Signaturefd LLC grew its holdings in shares of Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after acquiring an additional 125 shares during the last quarter. Institutional investors own 97.25% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

EHC has been the subject of several analyst reports. KeyCorp upped their target price on Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a report on Monday, February 10th. William Blair restated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. StockNews.com cut shares of Encompass Health from a "buy" rating to a "hold" rating in a research report on Thursday. Barclays raised their target price on Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a research report on Friday, February 7th. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $110.00 price target on shares of Encompass Health in a research report on Tuesday, February 11th. One analyst has rated the stock with a hold rating, nine have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $107.67.

Insiders Place Their Bets

In other news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 2.10% of the company's stock.

Encompass Health Stock Down 2.2 %

Shares of Encompass Health stock traded down $2.18 during trading on Monday, hitting $95.78. 460,999 shares of the stock traded hands, compared to its average volume of 685,686. The company has a fifty day moving average price of $99.25 and a two-hundred day moving average price of $97.75. Encompass Health Co. has a twelve month low of $78.53 and a twelve month high of $104.55. The stock has a market cap of $9.65 billion, a P/E ratio of 21.48, a PEG ratio of 2.31 and a beta of 0.87. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05.

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Equities research analysts predict that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.71%. Encompass Health's dividend payout ratio (DPR) is currently 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.